BCRX
BCRX
US09058V1035
BioCryst Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.18B EUR
2.55B EUR
2.42B EUR
1.66B EUR
Enterprise Value
2.6B EUR
3.19B EUR
3.06B EUR
2.01B EUR
Valuation Multiples
Trailing P/E
--
--
--
6.3x
Forward P/E
9.1x
--
--
--
Price to Sales
2.32x
2.71x
2.73x
2.28x
Price to Book
--
--
--
--
EV/Revenue
2.77x
3.39x
3.46x
2.76x
EV/EBITDA
6.01x
--
--
5.91x
Price to FCF (P/FCF)
6.75x
6.84x
7.79x
4.46x
EV/FCF
8.04x
8.55x
9.87x
5.4x
FCF Yield
14.81%
14.63%
12.83%
22.42%
ende